Physician
Gorman, Matthew
Gorman, Matthew was paid $1.11M by Medicaid between Mar 2021 and Dec 2024, across 44 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.
33Billing provider infoGORMAN, MATTHEW
WASHINGTON, IL 61571
WASHINGTON, IL 61571
33aNPI1427130392assigned 10/20/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.11M
24GClaims29,558
24DCodes billed44
24AFirst – last monthMar 2021 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Illinois
Rank by total paid#48 of 3,722
Median peer was paid$26K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 19,274 | $668K | |
| 2022 | 314 | $14K | |
| 2023 | 5,777 | $193K | |
| 2024incomplete | 4,193 | $233K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 52% | 12,478 | 10,906 | $575K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 3,779 | 3,290 | $131K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.7% | 2,088 | 1,859 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 1,758 | 1,555 | $54K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.7% | 558 | 501 | $41K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 2,489 | 2,300 | $38K |
| 59430 | 2.9% | 216 | 190 | $32K | |
| 0500F | 2.6% | 271 | 271 | $28K | |
| 87428 | 1.9% | 334 | 292 | $21K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 613 | 535 | $18K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 417 | 377 | $13K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 102 | 90 | $8K |
32 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 252 | $5K |
| 73610 | <1% | 204 | $5K | |
| 73630 | <1% | 240 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 220 | $3K |
| 73130 | <1% | 176 | $3K | |
| 12001 | <1% | 45 | $3K | |
| 81002 | <1% | 1,145 | $3K | |
| 87807 | <1% | 295 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 40 | $3K |
| 81025 | <1% | 517 | $3K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 169 | $2K |
| 73564 | <1% | 97 | $2K | |
| 90715 | <1% | 60 | $2K | |
| 73110 | <1% | 82 | $2K | |
| 69209 | <1% | 154 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 17 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $934.18 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 89 | $882.90 |
| 73140 | <1% | 47 | $819.11 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $667.03 |
| 73030 | <1% | 29 | $599.40 | |
| 73080 | <1% | 28 | $496.25 | |
| 99421 | <1% | 30 | $395.70 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $261.00 |
| 73090 | <1% | 14 | $221.21 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 152 | $195.36 |
| 81003 | <1% | 92 | $192.77 | |
| 82962 | <1% | 72 | $140.89 | |
| 86308 | <1% | 19 | $91.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 54 | $63.11 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 54 | $59.05 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 18 | $1.96 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.